Clinical Trials Sponsored by SeeCure LLC

Total 10736 results

SeeCure LLC

Unknown

The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer

Breast Cancer

United States
GeneCure Biotechnologies

Unknown

Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

COVID
GeneCure Biotechnologies

Unknown

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects (GCHT01)

HIV Infections

United States
OBEcure Ltd.

Completed

Evaluation of Co-Administration of Betahistine as Adjunctive to Olanzapine in Healthy Subjects

Healthy

Romania
GeneCure Biotechnologies

Recruiting

Therapeutic Hepatitis C Virus Vaccine

Chronic Hepatitis C Infection

United States
OBEcure Ltd.

Terminated

Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment

Weight Gain

Canada, Israel
OBEcure Ltd.

Completed

The Effect of Betahistine on Body Weight in Obese Subjects

Obesity

United States
OBEcure Ltd.

Completed

Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects

Healthy

Romania
OBEcure Ltd.

Terminated

A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin

Hypercholesterolemia

Israel
iECURE, Inc.

Recruiting

An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency (OTC-HOPE)

Urea Cycle Disorders, Inborn | Ornithine Transcarbamylase Deficiency | Ornithine Transcarbamylase Deficiency Disease | Ornithine Carbamoyltransferase Deficiency (Disorder)

United Kingdom
IceCure Medical Ltd.

Active, not recruiting

Cryoablation of Low Risk Small Breast Cancer- Ice3 Trial

Breast Cancer

United States
IceCure Medical Ltd.

Completed

ICE-SENSE™ Cryotherapy for Breast Fibroadenoma Trial (ICE-CRYSTAL)

Fibroadenoma

Czechia, Germany, Israel
IceCure Medical Ltd.

Withdrawn

Laparoscopic Cryoablation of Uterine Fibroids (UFREEZE-01)

Symptomatic Uterine Fibroids

Israel
IceCure Medical Ltd.

Completed

Cryotherapy for Breast Cancer Trial (ICE-BREACCER)

Breast Carcinoma

Czech Republic
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Advanced Solid Tumors | Relapsed Or Refractory Non-Hodgkin Lymphoma

China
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

A Study to Assess YH003 in Combination With Pebolizumab and Albumin Paclitaxel Injection in Subjects With Unresectable/Metastatic Mucosal Melanoma

Mucosal Melanoma

China
Eucure (Beijing) Biopharma Co., Ltd

Completed

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Cancer

Australia
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects With Advanced Solid Tumors

Solid Tumor

Australia
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

A Study to Assess YH002 in Combination With YH001 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China, Australia
Eucure (Beijing) Biopharma Co., Ltd

Completed

A Study to Evaluate YH003 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Eucure (Beijing) Biopharma Co., Ltd

Completed

A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Eucure (Beijing) Biopharma Co., Ltd

Completed

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

Australia
Eyecure Therapeutics Inc.
Beijing Tongren Hospital

Unknown

Treatment of RP and LCA by Primary RPE Transplantation

Leber Congenital Amaurosis, Retinitis Pigmentosa

China
Eucure (Beijing) Biopharma Co., Ltd

Completed

A Study to Assess YH001 in Combination With Toripalimab Injection in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

Australia
Eucure (Beijing) Biopharma Co., Ltd

Active, not recruiting

A Study to Assess YH003 in Combination With Toripalimab(Anti-PD-1 mAb) Injection in Patients With Cancers

Melanoma | Pancreatic Ductal Adenocarcinoma

United States, Australia
Eucure (Beijing) Biopharma Co., Ltd

Withdrawn

A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC (YH001)

HCC | NSCLC Stage IV | NSCLC Stage IIIB

China, Australia, Taiwan, Armenia, Austria
Eucure (Beijing) Biopharma Co., Ltd

Completed

A Study to Evaluate the Safety, Tolerability and How YH002 Enters, Moves Through and Exits the Body in Subjects With Advanced Solid Malignancies

Advanced Solid Malignancies

Australia
Mustafa Sahin
Novartis Pharmaceuticals; Autism Speaks; Tuberous Sclerosis Alliance; Seizure Tracker...

Completed

Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) (TSC)

Tuberous Sclerosis Complex

United States
SeaCare Health Services
New Hampshire Charitable Foundation

Terminated

SeaCare's Care Coordination for Diabetes Management in a Primary Care Office

Type 2 Diabetes

United States
OBEcure Ltd.
International Antiviral Therapy Evaluation Center

Completed

Efficacy Study of Betahistine on Body Weight in Obese Female Subjects

Obesity

Belgium, Germany, Netherlands
Arthritis Northwest PLLC
Epigenesys LLC

Unknown

Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

Arthritis, Rheumatoid

United States
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
Guangzhou Medical University
Ningbo SensCure Biotechnology Co., Ltd.

Recruiting

Single-center Clinical Study on the Safety and Effect of Bronchoscopic Cryotherapy in Patients With Chronic Cough (ColdCough)

Chronic Cough

China
Dana-Farber Cancer Institute
Secura Bio, Inc.

Recruiting

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

Chronic Lymphocytic Leukemia | Richter Syndrome

United States
Dana-Farber Cancer Institute
Secura Bio, Inc.

Active, not recruiting

A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL

Chronic Lymphocytic Leukemia

United States
Synochi, LLC
LAC+USC Medical Center

Not yet recruiting

Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple
Abdullah Kutlar
Secura Bio, Inc.

Recruiting

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease (LBH589)

Sickle Cell Disease

United States
LLS PedAL Initiative, LLC
Kura Oncology

Not yet recruiting

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Relapsed/Refractory KMT2A-r Acute Leukemia | Relapsed/Refractory NUP98-r Acute Leukemia | Relapsed/Refractory NPM1-m Acute Leukemia
Derm Research, PLLC
WFH MEDICAL, LLC

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Acne Vulgaris

United States
University Medical Center Groningen
University of Twente; Vivisol; Löwenstein BV; Sencure BV

Not yet recruiting

Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach (NOCTIVENT)

Chronic Respiratory Failure | Non-invasive Ventilation
Verily Life Sciences LLC
The Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation

Completed

ARDA Software for the Detection of mtmDR

Diabetic Retinopathy

United States
Dana-Farber Cancer Institute
Celgene; Secura Bio, Inc.

Terminated

Phase I Study of Marizomib + Panobinostat for Children With DIPG (DIPG)

Pediatric Cancer | Diffuse Intrinsic Pontine Glioma | Pediatric Brain Tumor | Diffuse Glioma | Pediatric Brainstem Glioma | Pediatric Brainstem Gliosarcoma, Recurrent

United States
MedRegen LLC
Johns Hopkins University; ICON plc

Recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

COVID-19 | ARDS, Human | Regeneration | Stem Cells

United States
Redx Pharma Plc
Merck Sharp & Dohme LLC

Completed

A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (KEYNOTE-E86)

Advanced Solid Tumours

United Kingdom, Australia
4D pharma plc
Merck Sharp & Dohme LLC

Terminated

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Melanoma | Renal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Oncology

United States
IVFarma LLC
BridgePharm LLC; GlobalPharma LLC

Completed

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

Infertility, Female

Russian Federation
European Institute of Oncology
Fondazione Umberto Veronesi; IceCure Medical Ltd.

Recruiting

Percutaneous Cryoablation of Low-risk Early Breast Cancer (PRECICE)

Breast Cancer

Italy
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation

Clinical Trials Sponsored by SeeCure LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations